Literature DB >> 9258970

Opsoclonus-myoclonus syndrome with abnormal single photon emission computed tomography imaging.

K Oguro1, J Kobayashi, H Aiba, H Hojo.   

Abstract

The single photon emission computed tomography (SPECT) findings in 2 patients with opsoclonus-myoclonus syndrome (OMS) who had similar symptoms in the acute stage of the disease are described. In 1 patient with encephalitis, SPECT showed increased blood flow in most of the cerebellum; the highest accumulation of the radiotracer was found in the cerebellar vermis and neighboring structures. These changes disappeared with clinical improvement. In the other patient with chronic OMS, SPECT demonstrated hypoperfusion in most of the cerebellum. Our results suggest that the cerebellum, particularly its middle portion, is involved in the generation of OMS. SPECt is a useful method that enables us to detect in vivo functional impairment in patients with OMS.

Entities:  

Mesh:

Year:  1997        PMID: 9258970     DOI: 10.1016/s0887-8994(97)00031-3

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  7 in total

1.  Longitudinal multi-modal neuroimaging in opsoclonus-myoclonus syndrome.

Authors:  Sun-Young Oh; Rainer Boegle; Peter Zu Eulenburg; Matthias Ertl; Ji-Soo Kim; Marianne Dieterich
Journal:  J Neurol       Date:  2017-01-04       Impact factor: 4.849

2.  Clonazepam responsive opsoclonus myoclonus syndrome: additional evidence in favour of fastigial nucleus disinhibition hypothesis?

Authors:  Vimal Kumar Paliwal; Satish Chandra; Ritu Verma; Jayantee Kalita; Usha K Misra
Journal:  J Neural Transm (Vienna)       Date:  2010-01-22       Impact factor: 3.575

3.  A GABAergic Dysfunction in the Olivary-Cerebellar-Brainstem Network May Cause Eye Oscillations and Body Tremor. II. Model Simulations of Saccadic Eye Oscillations.

Authors:  Lance M Optican; Elena Pretegiani
Journal:  Front Neurol       Date:  2017-08-04       Impact factor: 4.003

4.  Opsoclonus-myoclonus syndrome with severe clinical course and beneficial outcome: A case report.

Authors:  Ewa Koziorowska-Gawron; Magdalena Koszewicz; Joanna Bladowska; Maria Ejma; Slawomir Budrewicz
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

5.  Posterior Reversible Encephalopathy Syndrome Presenting as Opsoclonus-Myoclonus.

Authors:  Torrey Boland; Jamie Strause; Myra Hu; Dolores Santamaria; Tsao-Wei Liang; Daniel Kremens; Robert Sergott; Michael Moussouttas
Journal:  Neuroophthalmology       Date:  2012-07-02

6.  Opsoclonus-myoclonus syndrome associated with multiple system atrophy.

Authors:  Kazumasa Shindo; Akiko Onohara; Takanori Hata; Fumikazu Kobayashi; Kaori Nagasaka; Takamura Nagasaka; Yoshihisa Takiyama
Journal:  Cerebellum Ataxias       Date:  2014-11-01

7.  Temporal Changes in Brain Perfusion in a Patient with Myoclonus and Ataxia Syndrome Associated with COVID-19.

Authors:  Kenta Osawa; Atsuhiko Sugiyama; Akiyuki Uzawa; Shigeki Hirano; Tatsuya Yamamoto; Masahiko Nezu; Nobuyuki Araki; Hiroki Kano; Satoshi Kuwabara
Journal:  Intern Med       Date:  2022-02-01       Impact factor: 1.282

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.